Tert-butyl 4-[[(2S)-2-(4-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetyl]amino]benzoate
C24H29BrN2O5 — CID 156565273
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[[(2S)-2-(4-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetyl]amino]benzoate
Tert-butyl 4-[[(2S)-2-(4-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetyl]amino]benzoate (PubChem CID 156565273) has the molecular formula C24H29BrN2O5 and a molecular weight of 505.41 g/mol. Its IUPAC name is tert-butyl 4-[[(2S)-2-(4-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetyl]amino]benzoate.
Molecular Properties
| Compound Name | Tert-butyl 4-[[(2S)-2-(4-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetyl]amino]benzoate |
|---|---|
| PubChem CID | 156565273 |
| Molecular Formula | C24H29BrN2O5 |
| Molecular Weight | 505.41 g/mol |
| Exact Mass | 504.13 |
| IUPAC Name | tert-butyl 4-[[(2S)-2-(4-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetyl]amino]benzoate |
| SMILES | CC(C)(C)OC(=O)N[C@H](C(=O)Nc1ccc(C(=O)OC(C)(C)C)cc1)c1ccc(Br)cc1 |
| InChI | InChI=1S/C24H29BrN2O5/c1-23(2,3)31-21(29)16-9-13-18(14-10-16)26-20(28)19(15-7-11-17(25)12-8-15)27-22(30)32-24(4,5)6/h7-14,19H,1-6H3,(H,26,28)(H,27,30)/t19-/m0/s1 |
| InChIKey | KXBGHGWDVQPGKS-IBGZPJMESA-N |
| XLogP | 5.61 |
| TPSA | 93.73 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 505.41 |
| LogP ≤ 5 | 5.61 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156565273 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.